Not So Different: A Podcast from The Center for Biosimilars

S6 Ep18: Biosimilars Regulatory Roundup For September 2023– Podcast Edition

Listen

Description


Show Notes



House Committee Hearing Addresses PBMs, Anticompetitive Drug Pricing Tactics



Part 2: FDA Workshop Shares Manufacturer Perspective on the Value of Clinical Efficacy Testing



Part 1: FDA Workshop Highlights Global Regulatory View on Biosimilar Development



Part 3: BioRationality—FDA Webinar on Biosimilars Efficacy Testing Marks Major Step Forward



Alvotech’s Stelara Biosimilar Approved in Japan



EC Approves First MS Biosimilar; Coherus Receives CRL for Neulasta Onpro Competitor



European Commission Approves First Aflibercept Biosimilar



Regulatory Updates From Around the Globe Provide Hope for Biosimilars